−4.78 M USD
0.00 USD
About Jupiter Neurosciences, Inc.
Sector
CEO
Christer Rosén
Headquarters
Jupiter
Website
FIGI
BBG0130XFNK0
Jupiter Neurosciences, Inc. is a clinical-stage pharmaceutical company engaged in treating neuroinflammation with a current focus on CNS disorders and rare diseases. The firm offers JOTROL, an enhanced orally administered resveratrol formulation, designed to deliver therapeutically relevant, safe levels of resveratrol. The company was founded by Christer Rosén, Alexander Rosén, Claes Wahlestedt, Marshall Hayward, and Shaun P. Brothers in January 2016 and is headquartered in Jupiter, FL.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of JUNS is 10.94 USD — it has decreased by −3.59% in the past 24 hours. Watch Jupiter Neurosciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Jupiter Neurosciences, Inc. stocks are traded under the ticker JUNS.
JUNS stock has risen by 2.32% compared to the previous week, the month change is a 175.50% rise, over the last year Jupiter Neurosciences, Inc. has showed a 173.50% increase.
JUNS reached its all-time high on Dec 19, 2024 with the price of 19.51 USD, and its all-time low was 3.86 USD and was reached on Dec 3, 2024. View more price dynamics on JUNS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
JUNS stock is 10.09% volatile and has beta coefficient of 12.76. Track Jupiter Neurosciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Jupiter Neurosciences, Inc. there?
Today Jupiter Neurosciences, Inc. has the market capitalization of 364.81 M, it has increased by 1.41% over the last week.
Yes, you can track Jupiter Neurosciences, Inc. financials in yearly and quarterly reports right on TradingView.
JUNS net income for the last quarter is −591.02 K USD, while the quarter before that showed 313.12 K USD of net income which accounts for −288.75% change. Track more Jupiter Neurosciences, Inc. financial stats to get the full picture.
No, JUNS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, JUNS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Jupiter Neurosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.